Lamb–Shaffer syndrome: 20 Spanish patients and literature review expands the view of neurodevelopmental disorders caused by SOX5 haploinsufficiency
Clinical Genetics · 2023
DOI: 10.1111/cge.14423 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Genetics, 2023. Verfasst von Jair Tenorio-Castano und 11 weiteren Autor:innen. Beteiligte Einrichtung: CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain. Hauptthemen laut MEDLINE: Intellectual Disability, Autism Spectrum Disorder, Neurodevelopmental Disorders. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: European Regional Development Fund, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Lamb–Shaffer Syndrome (LSS; OMIM #616803; ORPHA #313892; ORPHA #313884) is an infrequent genetic disorder that affects multiple aspects of human development especially those related to the development of the nervous system. LSS is caused by variants in the SOX5 gene. At the molecular level, SOX5 gene encodes for a transcription factor containing a High Mobility Group (HMG) DNA‐Binding domain with relevant functions in brain development in different vertebrate species. Clinical features of Lamb–Shaffer syndrome may include intellectual disability, delayed speech and language development, attention deficits, hyperactivity, autism spectrum disorder, visual problems and seizures. Additionally, patients with the syndrome may present distinct facial dimorphism such as a wide mouth with full lips, small chin, broad nasal bridge, and deep‐set eyes. Other physical features that have been reported in some patients include short stature, scoliosis, and joint hypermobility. Here, we report the clinical and molecular characterization of a Spanish LSS cohort of new 20 patients and review all the patients published so far which amount for 111 patients. The most frequent features included developmental delay, intellectual disability, visual problems, poor speech development and facial dysmorphic features. Strikingly, pain insensitivity and hypermetropia seems to be more frequent than previously reported, based on the frequency seen in the Spanish cohort. Eighty‐three variants have been reported so far, single nucleotide variants (SNV) and copy number variants represent 47% and 53%, respectively, from the total of variants reported. Similarly to previous reports, the majority of the SNVs variants of the novel patients reported herein fall in the HMG domain of the protein. However, new variants, affecting other functional domains, were also detected. In conclusion, LLS is a rare genetic disorder mostly characterized by a wide range of developmental and neurological symptoms. Early diagnosis would allow to start of care programs, clinical follow up, prospective studies and appropriate genetic counseling, to promote clinical and social improvement to have profound lifelong benefits for patients and their families. Further research is needed to better understand the underlying mechanisms of the syndrome related to SOX5 haploinsufficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.
- INGEMM-IdIPAZ, Institute of Medical and Molecular Genetics, Hospital Universitario La Paz, Madrid, Spain.
- ITHACA, European Reference Network, Brussels, Belgium.
- Primary Care Pediatrician, SERMAS, Madrid, Spain.
- Department of Radiology, Hospital Universitario La Paz, Madrid, Spain.
- Instituto Cajal, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
ORCID-Profile: Alejandro Parra, Aixa V Morales, Pablo Lapunzina
Förderung
- European Regional Development Fund
- Instituto de Salud Carlos III
Zitieren
APA
Tenorio-Castano, J., Gómez, Á. S., Coronado, M., Rodríguez-Martín, P., Parra, A., Pascual, P., Cazalla, M., Gallego, N., Arias, P., Morales, A. V., Nevado, J., & Lapunzina, P. (2023). Lamb–Shaffer syndrome: 20 Spanish patients and literature review expands the view of neurodevelopmental disorders caused by SOX5 haploinsufficiency. Clinical Genetics. https://doi.org/10.1111/cge.14423
Vancouver
Tenorio-Castano J, Gómez ÁS, Coronado M, Rodríguez-Martín P, Parra A, Pascual P, et al. Lamb–Shaffer syndrome: 20 Spanish patients and literature review expands the view of neurodevelopmental disorders caused by SOX5 haploinsufficiency. Clinical Genetics. 2023. doi:10.1111/cge.14423
BibTeX
@article{TenorioCastano2023,
author = {Tenorio-Castano, Jair and Gómez, Ángela Sánchez-Algaba and Coronado, Mónica and Rodríguez-Martín, Pilar and Parra, Alejandro and Pascual, Patricia and Cazalla, Mario and Gallego, Natalia and Arias, Pedro and Morales, Aixa V and Nevado, Julián and Lapunzina, Pablo},
title = {Lamb–Shaffer syndrome: 20 Spanish patients and literature review expands the view of neurodevelopmental disorders caused by SOX5 haploinsufficiency},
journal = {Clinical Genetics},
year = {2023},
doi = {10.1111/cge.14423}
}
EUVIMED